Indication
Renal Protection
1 clinical trial
2 products
Clinical trial
Effect of Atorvastatin as a Renal Protection in Patients With Systemic Inflammatory Response Syndrome Using Renal Arterial Resistive IndexStatus: Recruiting, Estimated PCD: 2023-12-12
Product
AtorvastatinProduct
Placebo